chevron_leftBack
As of 7 June 2026, Unilever Consumer Care Ltd. has a market cap of $326.4M USD, ranking #18060 globally and #19 in Bangladesh.
It ranks #1641 in the Healthcare sector, and #591 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$326.4MUSD
40.03B BDT
Enterprise Value
$302.32MUSD
37.12B BDT
Revenue (TTM)
$29.6MUSD
3.63B BDT
EBITDA (TTM)
$5.47MUSD
671.59M BDT
Net Income (TTM)
$5.89MUSD
722.72M BDT
EBITDA Margin
18%
Profit Margin
20%
PE Ratio
55.4
PS Ratio
11.0
PB Ratio
19.3
EV/EBITDA
53.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Khan Salahuddin Minhaj
open_in_new
Employees
61
Founded
1974
Website
unileverconsumercarebd.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.3% | 0.6% | -3.6% | -4.5% | -13% | -12% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
UNILEVERCL
Unilever Consumer Care Ltd
ISIN: BD0454GLAXO1
Shares Out.:
Shares Outstanding:
19.274M1
Shares Float:
1.265M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2,077.10 BDT |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Unilever Consumer Care Ltd.
Unilever Consumer Care Limited manufactures and markets consumer healthcare products in Bangladesh. The company offers horlicks malt-flavored health food drink; maltova chocolate-caramel flavored health drink; boost chocolate drink; and glucose powder under the GlucoMax D brand. The company was formerly known as GlaxoSmithKline Bangladesh Limited and changed its name to Unilever Consumer Care Limited in August 2020. Unilever Consumer Care Limited was incorporated in 1974 and is based in Dhaka, Bangladesh. Unilever Consumer Care Limited is a subsidiary of Unilever Overseas Holdings BV.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
DSE: SQURPHARMA
|
$1.54B
373%
189.43B BDT
|
7.3
|
|
DSE: BXPHARMA
|
$417.54M
28%
51.21B BDT
|
8.1
|
|
DSE: RENATA
|
$389.85M
19%
47.82B BDT
|
18.9
|
|
DSE: BEACONPHAR
|
$194.17M
-41%
23.82B BDT
|
19.2
|
|
DSE: ACI
|
$145.51M
-55%
17.85B BDT
|
154.3
|
|
DSE: ACMELAB
|
$130.77M
-60%
16.04B BDT
|
6.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
233K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
168K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
110K%
|
97.4
|
|
SIX: RO
|
$324.68B
99K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
89K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
85K%
218.9B CHF
|
20.5
|
chevron_leftBack